Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death

Fig. 5

Effect of Amygdalin or Sorafenib single and combined treatment on expression of apoptosis-autophagy related genes: (A) HepG2; (B) WI-38 cells. Results are presented as mean ± SEM (n = 3). * (P ≤ 0.05), ** (P ≤ 0.01) *** (P ≤ 0.001) compared to control

Back to article page